SIRT1 and breast cancer: Sirt1 also plays a confirmed role in some tumor cells, such as ovarian, thyroid, pancreatic cancers [21], and breast cancer [22]; meanwhile, Sirt1 can serve as useful biomarkers for predicting WEE1 inhibitor sensitivity or resistance [23].